Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Risk of Cardiovascular Events in Patients Using Tocilizumab as Compared With Other Biologics in Multiple Large Healthcare Databases

NCT02797769 is registered in ClinicalTrials.gov with Hoffmann-La Roche as lead sponsor.

NCT NCT02797769
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02797769 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Risk of Cardiovascular Events in Patients Using Tocilizumab as Compared With Other Biologics in Multiple Large Healthcare Databases
Lead sponsor
Hoffmann-La Roche
Phase
Observational
Overall status
Completed
Start date
June 2, 2016
Completion date
June 2, 2016
Enrollment
48,950 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

rheumatoid arthritis